HER2 expression / amplification in patients with biliary tract cancer

Clinical trials for HER2 expression / amplification in patients with biliary tract cancer explained in plain language.

Never miss a new study

Get alerted when new HER2 expression / amplification in patients with biliary tract cancer trials appear

Sign up with your email to follow new studies for HER2 expression / amplification in patients with biliary tract cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New targeted therapy aims at Hard-to-Treat bile duct cancers

Disease control Ongoing

This phase 2 trial tests an experimental drug called SHR-A1811 in people with advanced biliary tract cancer that has HER2 expression or amplification and has stopped responding to earlier treatments. The drug is an antibody-drug conjugate designed to deliver a chemotherapy-like p…

Matched conditions: HER2 EXPRESSION / AMPLIFICATION IN PATIENTS WITH BILIARY TRACT CANCER

Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

HER2 expression / amplification in patients with biliary tract cancer

Get alerted when new HER2 expression / amplification in patients with biliary tract cancer trials appear

New targeted therapy aims at Hard-to-Treat bile duct cancers